These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23221487)

  • 1. c-myc and cutaneous vascular neoplasms.
    Feller JK; Mahalingam M
    Am J Dermatopathol; 2013 May; 35(3):364-9. PubMed ID: 23221487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on vascular neoplasms.
    Sangüeza OP
    Dermatol Clin; 2012 Oct; 30(4):657-65, vi. PubMed ID: 23021052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
    Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
    Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
    Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
    J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
    Shon W; Sukov WR; Jenkins SM; Folpe AL
    Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc in Kaposi's sarcoma: analyses by fluorescent in situ hybridization and immunohistochemistry.
    Feller K; Yang S; Tung N; Lee J; Mahalingam M
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):120-4. PubMed ID: 22882520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
    Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
    J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
    Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
    J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
    Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
    Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression.
    von Rahden BH; Stein HJ; Pühringer-Oppermann F; Sarbia M
    Neoplasia; 2006 Sep; 8(9):702-7. PubMed ID: 16984727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism.
    Knies-Bamforth UE; Fox SB; Poulsom R; Evan GI; Harris AL
    Cancer Res; 2004 Sep; 64(18):6563-70. PubMed ID: 15374969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
    Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
    J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
    Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
    Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
    Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
    Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
    Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WT1 expression in angiogenic tumours of the skin.
    Timár J; Mészáros L; Orosz Z; Albini A; Rásó E
    Histopathology; 2005 Jul; 47(1):67-73. PubMed ID: 15982325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers.
    Park K; Kwak K; Kim J; Lim S; Han S
    Hum Pathol; 2005 Jun; 36(6):634-9. PubMed ID: 16021569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
    Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
    Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.